0001773751-22-000196.txt : 20220919 0001773751-22-000196.hdr.sgml : 20220919 20220919191003 ACCESSION NUMBER: 0001773751-22-000196 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220915 FILED AS OF DATE: 20220919 DATE AS OF CHANGE: 20220919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Maltz Jules A. CENTRAL INDEX KEY: 0001553254 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38986 FILM NUMBER: 221251746 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 2, SUITE 250 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 4 1 wf-form4_166362898616806.xml FORM 4 X0306 4 2022-09-15 0 0001773751 Hims & Hers Health, Inc. HIMS 0001553254 Maltz Jules A. 2269 CHESTNUT STREET, #523 SAN FRANCISCO CA 94123 1 0 1 0 Class A Common Stock 2022-09-15 4 M 0 2448 A 33105 D Class A Common Stock 125000 I Held by Jules Maltz and Kelly Greenwood Fam Tr UA 07/31/2018 Class A Common Stock 53974 I Held by Institutional Venture Partners XV Executive Fund, L.P. Class A Common Stock 10147758 I Held by Institutional Venture Partners XV, L.P. Class A Common Stock 10201746 I Held by Institutional Venture Partners XVI, L.P. Restricted Stock Unit 2022-09-15 4 M 0 4 0 D Class A Common Stock 4.0 44 D Restricted Stock Unit 2022-09-15 4 M 0 217 0 D Class A Common Stock 217.0 2179 D Restricted Stock Unit 2022-09-15 4 M 0 2227 0 D Class A Common Stock 2227.0 22267 D The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Mr. Maltz is a managing director of Institutional Venture Management XV LLC, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and Institutional Venture Management XVI LLC, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of March 15, 2021. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. /s/ Alexandra Cotter Wilkins, Attorney-in-Fact 2022-09-19 EX-24 2 poa-maltz.htm EX 24 POA

POWER OF ATTORNEY

The undersigned, as a Section 16 reporting person of Hims & Hers Health, Inc., a Delaware corporation (the "Company"), hereby constitutes and appoints each of Soleil Boughton, Alexandra Cotter Wilkins,
Carly Larson and Kimberly Mather as the undersigned's true and lawful attorney-in-fact to:

(1) complete and execute Form ID, "Update Passphrase Confirmation" form and Forms 3, 4 and 5 and other forms and all amendments thereto as such attorney-in-fact shall in his or her discretion
determined to be required or advisable pursuant to Section 16 of the Securities Exchange Act of 1934 (as amended) and the rules and regulations promulgated thereunder, or any successor laws and regulations,
as a consequence of the undersigned's ownership, acquisition or disposition of securities of the Company; and

(2) do all acts necessary in order to file such forms with the Securities and Exchange Commission, any securities exchange or national association, the Company and such other person or agency as the
attorney-in-fact shall deem appropriate.

The undersigned hereby ratifies and confirms all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof. The undersigned acknowledges that the foregoing attorneys-in-fact,
in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with the Securities Exchange Act of 1934, as amended.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities
issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. The undersigned hereby confirms that this Power of Attorney supersedes and
replaces any previous Power of Attorney related to the subject matter herein.


IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date set forth below.




/s/ Jules Maltz
Jules Maltz
7/28/2022